Mitochondrial Replacement in Ukraine

Mitochondrial replacement is an experimental method within IVF, developed so that a woman with a mutation in her mitochondrial DNA can have a child who is genetically her own without a severe mitochondrial disease. The nuclear genetic material of the intended parents is transferred into an egg or zygote from a donor with healthy mitochondria. There are few such clinical programmes in the world: in the United Kingdom the method is used under licence from the regulator, the HFEA, and each case is approved individually. The long-term consequences for the children are not yet known, and no benefit has been proven for infertility or "old" eggs. On this page we explain honestly how the method works, who it is considered for, what its limitations are and what alternatives exist.
Request a consultation
AnaesthesiaIntravenous sedation during egg retrieval, as in standard IVF
DurationAs for an IVF cycle, plus time for genetic counselling and approvals
Hospital stayOutpatient
RecoveryUsually short-lived discomfort after egg retrieval

What mitochondrial replacement is and why it was developed

Mitochondria are structures inside the cell that produce energy. They have their own small DNA, and a child receives it only from the mother, together with the cytoplasm of the egg. If the mother's mitochondrial DNA carries a harmful mutation, it can be passed on to her children and cause a mitochondrial disease. These diseases mainly affect the organs that need a lot of energy: the brain, muscles, heart and eyes. Some of them are severe and incurable.

Mitochondrial replacement was developed to break this chain. The idea is to take the nuclear genetic material of the intended parents, which determines almost all of the child's traits, and place it in an egg or zygote from a donor with healthy mitochondria. The child inherits the nuclear genes of the mother and father, and the mitochondria from the donor.

This is why the method is sometimes called the "three-parent baby". The phrase is striking but inaccurate: mitochondrial DNA contains only a few dozen genes responsible for energy production, while nuclear DNA contains about twenty thousand. Appearance and almost all inherited traits are determined by the nuclear DNA, which the child receives from its parents.

It is important to understand the status of the method. It is an experimental procedure: it is used in only a few clinical programmes in the world under strict supervision, and there are still few children born this way worldwide. The long-term consequences for their health are not yet known. The method does not replace IVF and is not a way of increasing the chances of pregnancy.

MediUkraine is a treatment search service, not a clinic. If there is a mitochondrial disease in your family, we can help you find a fertility clinic for a consultation with a fertility specialist and a geneticist, and pass on your request. Whether mitochondrial replacement in particular is right for you, or whether there are safer options, is decided by the doctors after studying your genetic data.

Doctor consulting a patient in a clinic room
Why MediUkraine?
Your personal care
coordinator at MediUkraine
Contact the MediUkraine team

Coming to Ukraine for fertility treatment: what to expect

Travel. Ukrainian airspace is closed, so there are no commercial flights. Patients usually arrive overland from a neighbouring EU country, by car, bus or train.

Visas. Citizens of the EU, the United Kingdom and the United States do not need a visa for short stays in Ukraine. Rules depend on your citizenship, so check your own before booking.

Safety, plainly. Ukraine is at war. Air raid alerts occur across the country, and a procedure can be rescheduled because of one. Several governments advise against travel to Ukraine, and while that advice stands, ordinary travel and medical insurance is often void — confirm your cover with your insurer before you commit to anything. It is also worth asking the clinic how its laboratory and embryo storage are protected during power outages.

Language. MediUkraine handles correspondence with you in English. Ask the clinic which languages its doctors and coordinators use with international patients.

Payment. You pay the clinic directly. Our service is free of charge for you.

More on travel, safety and insurance: Safety and travel.

Who mitochondrial replacement is considered for

The method is considered for women who have a confirmed harmful mutation in their mitochondrial DNA.
Most often the families who come to this conversation are those who already have affected children or have suffered losses.
The method makes sense when simpler approaches do not help.
Its use for infertility due to egg quality remains disputed and unproven.

How to prepare for a conversation about mitochondrial replacement

  1. Start with an exact genetic diagnosis: which mutation it is and at what level.
  2. Have a consultation with a clinical geneticist who works with mitochondrial diseases.
  3. Find out the legal status of the method in the country where you plan treatment.
  4. Have the standard work-up before IVF.

Methods of mitochondrial replacement: how they differ

All methods of mitochondrial replacement work on the same principle: the patient's nuclear genetic material is transferred into a donor cell from which the donor's own nuclear material has been removed beforehand. They differ in the stage at which this is done: before fertilisation or after. All methods require two women and two stimulation cycles: the patient, who provides the nuclear material, and the donor, who provides eggs with healthy mitochondria.

Pronuclear transfer. The patient's and the donor's eggs are fertilised with the partner's sperm. The next day, when two pronuclei, the nuclei with the mother's and the father's genetic material, are visible in each zygote, the embryologist carefully removes the pronuclei from the patient's zygote under a microscope and transfers them into the donor's zygote, from which its own pronuclei have been removed beforehand. The resulting embryo is cultured further like an ordinary IVF embryo. This is the method used in Newcastle, the centre that was the first in the United Kingdom to receive an HFEA licence for mitochondrial donation.

Spindle transfer. Here the manipulation is done before fertilisation. In a mature egg the chromosomes are gathered into a compact structure, the spindle. The embryologist removes the spindle from the patient's egg and transfers it into the donor's egg, from which the donor's own spindle has been removed. The resulting egg is fertilised by ICSI. The advantage of the method is that a fertilised donor zygote does not have to be destroyed, which matters ethically to some people. Technically it is difficult, because the spindle is hard to see in a living egg without special equipment.

Other approaches. Polar body transfer and transfer of the nucleus of an immature egg have also been studied in laboratory research. These methods are still being studied mainly in the laboratory.

How mitochondrial replacement differs from cytoplasmic transfer. In the 1990s a different method was used in the United States: part of the cytoplasm of a donor egg was injected into the patient's egg in the hope of "boosting" it. Children were born, but safety questions arose, including the mixing of two women's mitochondria, and in 2001 the FDA effectively stopped these procedures. Modern mitochondrial replacement works differently: it transfers nuclear material rather than adding someone else's cytoplasm.

What is known about the results. In July 2025, researchers from Newcastle published a report in the New England Journal of Medicine on eight children born after pronuclear transfer. At the time of publication no signs of mitochondrial disease had been found in the children, and several children had early health problems that the researchers do not link to the method. At the same time, a small proportion of mitochondria carrying the mother's mutation was found in some of the children, well below the levels at which the disease is usually expected to appear. The researchers themselves describe the method as a way of reducing the risk rather than eliminating it entirely, and plan further follow-up of the children.

Why this is not "egg rejuvenation". Mitochondrial replacement is sometimes presented as a way of renewing the eggs of older women. But one of the main reasons fertility declines with age is errors in chromosome division, and in mitochondrial replacement the chromosomes move into the donor cell together with the patient's nuclear material. In other words, mitochondrial replacement does not solve the age-related problem. For women whose own eggs no longer offer a chance of pregnancy, the proven option worth discussing with the doctor is egg donation.

Legal status in different countries. In the United Kingdom the method was permitted by regulations of 2015, and the HFEA approved the first patients in 2018. In Australia a law permitted mitochondrial donation in 2022 within research and clinical trials. In the United States clinical use is effectively blocked. In Ukraine the method is not specifically regulated: Order No. 787 of the Ministry of Health of Ukraine, which sets out the procedure for using assisted reproductive technologies, does not specifically describe it. Isolated reports of experimental use of the method for infertility do not change its experimental status.

What patients from abroad should know

  • In Ukraine mitochondrial replacement is not specifically regulated by law.
  • You can start remotely, with your genetic documents and an online consultation.
  • If a mitochondrial disease is involved, compare all the options, not only mitochondrial replacement.
  • In terms of time on site, the programme is similar to an IVF cycle: you need to be there for stimulation and egg retrieval.
  • Think about follow-up after you return home.
  • Ask whether there are published results and whether the study is registered.

After the procedure: pregnancy and follow-up of the child

Physically, everything happens for the patient just as in standard IVF. After egg retrieval there may be short-lived discomfort in the lower abdomen and bloating. Severe pain, an abdomen that keeps getting bigger, shortness of breath or passing less urine are reasons to contact the clinic straight away because of the risk of ovarian hyperstimulation syndrome. Bed rest is not needed after embryo transfer.

Pregnancy is tested with an hCG blood test, usually 10–16 days after embryo transfer. As in standard IVF, a transfer does not always result in pregnancy, and the micromanipulation is complex, so not every reconstructed embryo develops.

During pregnancy prenatal diagnosis is usually offered: analysis of chorionic villus cells or amniotic fluid to check the level of mutant mitochondrial DNA in the fetus. These are invasive procedures with a small risk of complications, and the decision on them is made together with the clinical geneticist.

After birth the child is followed up for a long time: development is checked, as is the level of the mother's mitochondrial DNA in the blood and other tissues. The UK programme offers examinations of the children up to the age of five. This matters not only for the individual child but also for understanding the safety of the method as a whole.

It is also worth thinking about the future. If a girl is born, she will later pass mitochondria on to her own children, so the consequences of the method extend to future generations as well. That is why, in a 2016 report, the US National Academies of Sciences proposed transferring only male embryos at the first stage, and this question is still being discussed.

The family needs support too. Questions about the donor, and about how and when to tell the child about their origins, are not simple. Psychological counselling in such programmes is useful both before treatment and after the child is born.

How the programme works, step by step

Step 1. Genetic consultation. The geneticist reviews the report on the mutation, the level of heteroplasmy and the family history, and explains the risk for the future child and all the options, from genetic testing of embryos to donor eggs. A decision on mitochondrial replacement is considered only after this.

Step 2. Legal and ethical approval. In the United Kingdom each case is approved individually by the regulator, the HFEA; other countries have their own procedures. The couple signs detailed informed consent to the treatment, while prenatal diagnosis and long-term follow-up of the child are offered separately.

Step 7. Pregnancy and follow-up. Once pregnancy is confirmed, prenatal diagnosis is offered, and after birth the child is followed up for years. These data matter both for the family and for understanding the safety of the method.

What makes up the cost and what to ask the clinic

The quote for a mitochondrial replacement programme is broader than for standard IVF. It includes the IVF cycle for the patient, a full egg donation programme, micromanipulation, genetic testing at different stages, prenatal diagnosis and follow-up of the child. The clinic gives the exact cost and plan after a consultation and a review of the genetic data.

The most important question is whether the clinic has a regulator's licence or is working within a registered study with ethical approval. Ask to see the protocol, the ethics committee document and an explanation of the legal basis. If these are missing and the method is offered as an ordinary paid service, that is a serious reason to stop.

Ask about experience and results: how many such procedures this team has performed, whether the results have been published in peer-reviewed journals, how many children have been born and how they are followed up. General talk of "advanced technologies" is no substitute for data.

Find out how the carry-over of mutant mitochondria is measured: whether the level of mutant DNA is checked in embryos before transfer, what prenatal diagnosis is offered and what will be done if the level turns out to be high. These answers determine how far the risk is really reduced.

Discuss the alternatives and an honest assessment of the chances. A good clinic will compare mitochondrial replacement for you with genetic testing of embryos and with a donor egg programme, and explain why it recommends this particular option in your situation.

Risks, unknown consequences and safety

For the patient and the donor, the risks of stimulation and egg retrieval are the same as in standard IVF and egg donation: ovarian hyperstimulation syndrome, bleeding or infection after egg retrieval and, rarely, complications of anaesthesia. During pregnancy the general risks of IVF remain, and invasive prenatal diagnosis carries a small risk of complications.

The main risk of the method is the carry-over of some mutant mitochondria. During the manipulation a small number of the patient's mitochondria inevitably move across together with the nuclear material. There are usually few of them, but in some children in the UK programme mutant DNA was detected at a low level. The method therefore reduces the risk rather than guaranteeing its absence.

The phenomenon of "reversion" is discussed separately. In some laboratory studies on embryonic stem cells, a small initial proportion of the mother's mitochondria increased over time and displaced the donor's. How far this can happen in a child's body is not yet known, and that is exactly why the children are followed up for years.

The long-term consequences for the children's health are not yet known: the oldest children in the UK programme are still very young. There are theoretical questions about the compatibility of the parents' nuclear genetic material with the donor's mitochondria, which partly rest on animal studies. There is no clear answer to them yet.

The changes extend to future generations too. Mitochondria are inherited through the female line, so a girl born after mitochondrial replacement will in the future pass her own mitochondria, that is, mostly the donor's, on to her children. This is one of the reasons why the method is strictly regulated and why ethical debates around it continue.

In the United Kingdom, where results have been published, the method is used for clear indications, after genetic counselling, under a licence from the regulator, the HFEA, and with informed consent; prenatal diagnosis and long-term follow-up of the child are also offered. If there are no indications, no licence or no consent, the procedure is best declined. The decision always remains yours, and turning down mitochondrial replacement in favour of proven alternatives is a normal choice.

Related services

Frequently asked questions

Is it true that the child will have "three parents"?

Formally, the child receives DNA from three people, but the donor's contribution is very small. Mitochondrial DNA contains only a few dozen genes, which are responsible for energy production in the cell. The child receives the nuclear genes, on which appearance and most inherited traits depend, from the mother and father.

Under UK law the mitochondrial donor is not considered the child's parent. The legal status in other countries has to be clarified separately with a lawyer.

How much does mitochondrial replacement cost?

The cost is determined individually: this is an experimental procedure carried out within individual clinical programmes. The quote is made up of the IVF cycle for the patient, an egg donation programme, micromanipulation, genetic testing, prenatal diagnosis and follow-up of the child.

The clinic gives the exact cost and plan after a consultation and a review of the genetic data. First of all, find out whether the clinic has a regulator's licence or is working within a registered study with ethical approval.

Is mitochondrial replacement performed in Ukraine?

In Ukraine this method is not specifically regulated: Order No. 787 of the Ministry of Health of Ukraine, which sets out the procedure for using assisted reproductive technologies, does not specifically describe it. Experimental use of the method for infertility has been reported, but that does not make it a standard or proven service.

If you are offered mitochondrial replacement, ask for a written explanation of the legal basis and to see the ethical approval and the results. We can help you find a fertility clinic for a consultation, where the doctors will assess your situation and all the options.

Will the method help if my eggs are "old"?

No, there is no evidence of this. One of the main reasons fertility declines with age is errors in chromosome division, and in mitochondrial replacement the chromosomes move into the donor cell together with the patient's nuclear material. In other words, replacing the mitochondria does not fix the age-related problem.

Some research groups have studied mitochondrial replacement after repeated IVF failures, but there is no convincing evidence of benefit. For women whose own eggs offer no chance of pregnancy, the proven option worth discussing with the doctor is egg donation.

How effective is mitochondrial replacement?

There are still few data. In July 2025, researchers from Newcastle published a report in the New England Journal of Medicine on eight children born after pronuclear transfer. At the time of publication no signs of mitochondrial disease had been found in them, but a small level of the mother's mutant DNA was found in some.

The method is therefore described as a way of reducing the risk of passing on the disease, not eliminating it. The chance of pregnancy, as in any IVF, depends on age and on the number and quality of embryos, and some reconstructed embryos may not develop.

Is the method safe for the child in the long run?

The long-term consequences are not yet known: the oldest children born within the UK programme are still very young. The risk that a small proportion of the mother's mitochondria with the mutation will increase over time is being discussed, as is the question of compatibility between the parents' nuclear genes and the donor's mitochondria.

That is exactly why the children are followed up for years and the method is used only for strict indications and with permission from a regulator or an ethics committee.

What alternatives are there to avoid passing on the disease?

If the level of mutant DNA in the eggs is low, the risk can often be reduced with genetic testing of embryos: the embryo with the lowest level of the mutation is chosen for transfer. Donor eggs rule out transmission of a disease caused by a mutation in the mother's mitochondrial DNA, although the child then does not inherit the mother's nuclear genes.

Prenatal diagnosis during a natural pregnancy is also possible, but for mitochondrial diseases its result does not always make it possible to predict the course accurately. Which option suits you is worth discussing with a clinical geneticist.

Planning IVF in Ukraine?

Tell us about your situation: we will find a fertility clinic and pass on your request. The clinic will give you a treatment plan and a quote after the consultation.

Request a consultation →
Request a consultation